Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area for biology experiments has emerged as the key driver of trader sentiment around potential lab-leak risks. The facility supports Claude-powered protein design, robotic automation of experiments, and work on rare-disease targets, coinciding with the company’s September 2026 threat-intelligence report detailing blocked attempts to use its models for gain-of-function research on viruses such as chikungunya and avian influenza. This expansion into real biological material handling, while Anthropic simultaneously publishes metrics showing its models now leading 26% of internal R&D and urges industry-wide slowdowns, underscores the tension between capability gains and biosafety controls. Traders are watching for upcoming Life Sciences Verification Program grants, independent evaluations with partners like Accenture, and any further disclosures on lab operations or model releases that could alter perceived incident probabilities.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日新規
$22,577 Vol.
2026/12/31
2026年12月31日
3%
2027年6月30日
11%
$22,577 Vol.
2026年12月31日
$15,639 Vol.
3%
2027年6月30日
$6,938 Vol.
11%
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area for biology experiments has emerged as the key driver of trader sentiment around potential lab-leak risks. The facility supports Claude-powered protein design, robotic automation of experiments, and work on rare-disease targets, coinciding with the company’s September 2026 threat-intelligence report detailing blocked attempts to use its models for gain-of-function research on viruses such as chikungunya and avian influenza. This expansion into real biological material handling, while Anthropic simultaneously publishes metrics showing its models now leading 26% of internal R&D and urges industry-wide slowdowns, underscores the tension between capability gains and biosafety controls. Traders are watching for upcoming Life Sciences Verification Program grants, independent evaluations with partners like Accenture, and any further disclosures on lab operations or model releases that could alter perceived incident probabilities.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
マーケット開始日： Sep 18, 2026, 8:27 PM ET
音量
$22,577終了日
2027/07/01マーケット開始日
Sep 18, 2026, 8:27 PM ETリゾルバー
0x65070BE91...This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area for biology experiments has emerged as the key driver of trader sentiment around potential lab-leak risks. The facility supports Claude-powered protein design, robotic automation of experiments, and work on rare-disease targets, coinciding with the company’s September 2026 threat-intelligence report detailing blocked attempts to use its models for gain-of-function research on viruses such as chikungunya and avian influenza. This expansion into real biological material handling, while Anthropic simultaneously publishes metrics showing its models now leading 26% of internal R&D and urges industry-wide slowdowns, underscores the tension between capability gains and biosafety controls. Traders are watching for upcoming Life Sciences Verification Program grants, independent evaluations with partners like Accenture, and any further disclosures on lab operations or model releases that could alter perceived incident probabilities.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
音量
$22,577終了日
2027/07/01マーケット開始日
Sep 18, 2026, 8:27 PM ETリゾルバー
0x65070BE91...Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area for biology experiments has emerged as the key driver of trader sentiment around potential lab-leak risks. The facility supports Claude-powered protein design, robotic automation of experiments, and work on rare-disease targets, coinciding with the company’s September 2026 threat-intelligence report detailing blocked attempts to use its models for gain-of-function research on viruses such as chikungunya and avian influenza. This expansion into real biological material handling, while Anthropic simultaneously publishes metrics showing its models now leading 26% of internal R&D and urges industry-wide slowdowns, underscores the tension between capability gains and biosafety controls. Traders are watching for upcoming Life Sciences Verification Program grants, independent evaluations with partners like Accenture, and any further disclosures on lab operations or model releases that could alter perceived incident probabilities.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問